Equity Alert – The M&A Class Action Firm Announces the Investigation of La Jolla Pharmaceutical Co. – LJPC – QNT Press Release

[ad_1]

NEW YORK, July 16, 2022 /PRNewswire/ — Juan Monteverdefounder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York Cityis investigating La Jolla Pharmaceutical Co. (LJPC)relating to its proposed acquisition by Innovia, Inc. Under the terms of the agreement, LJPC shareholders are expected to receive $6.23 in cash per share they own. Click here for more information: http://monteverdelaw.com/case/la-jolla-pharmaceutical-co. It is free and there is no cost or obligation to you.